Band 5
Provided by Xiaomei Li
Ms. Li specializes in PE/VC, capital markets and M&A. She has extensive experience in PE/VC financing and has been in charge of numerous projects of great influence, covering industries such as life science and healthcare, AI, high-tech, intelligent manufacturing, new materials, clean energy, TMT, education, film and media, culture and entertainment, retail, finance, and human resources.
She has advised on numerous iconic projects, including investment deals representing prestigious private investment funds and institutions such as LYFE Capital, BioTrack Capital, CCB International, Shunwei Capital, Grand Flight Investment, Qiming Venture Partners, Huaxing Healthcare Fund, HJ Partners, Kaitai Capital, Source Code Capital, Matrix, Linear Capital, Qingsong Fund, Poly Capital, Phoenix Tree Capital, JD Group, and Legend. Her experience also includes advising on multiple capital markets projects such as MicroPort EP's listing on the STAR Market, JD.com's secondary listing in Hong Kong, as well as Hong Kong IPOs forJD Health, Maoyan Entertainment, China Renaissance, and Zhaogang. Com, and Nasdaq IPOs for Sogou and Burning Rock Biotech respectively.
Provided by Chambers
Li Xiaomei is noted in the market for her activity and expertise in private equity financing and venture capital deals as well as capital markets transactions. She represents investment firms and venture capital funds in their investments in the healthcare sector.
李晓梅律师在私募股权融资和风险投资交易以及资本市场交易方面的活动和专业知识在市场受到关注。她代表投资公司和风险投资基金对医疗保健行业进行投资。
